300204 舒泰神
已收盘 07-10 15:00:00
资讯
新帖
简况
舒泰神（300204）披露药品生产许可证变更公告，7月8日股价下跌3.06%
证券之星 · 07-08 22:14
舒泰神（300204）披露药品生产许可证变更公告，7月8日股价下跌3.06%
舒泰神（300204）披露召开2026年第一次临时股东会提示性公告，7月6日股价上涨4.93%
证券之星 · 07-06
舒泰神（300204）披露召开2026年第一次临时股东会提示性公告，7月6日股价上涨4.93%
7月1日舒泰神涨5.80%，景顺长城医疗健康混合A基金重仓该股
证券之星 · 07-01
7月1日舒泰神涨5.80%，景顺长城医疗健康混合A基金重仓该股
6月26日舒泰神跌7.62%，景顺长城医疗健康混合A基金重仓该股
证券之星 · 06-26
6月26日舒泰神跌7.62%，景顺长城医疗健康混合A基金重仓该股
6月24日舒泰神跌6.19%，景顺长城医疗健康混合A基金重仓该股
证券之星 · 06-24
6月24日舒泰神跌6.19%，景顺长城医疗健康混合A基金重仓该股
6月23日舒泰神涨11.22%，景顺长城医疗健康混合A基金重仓该股
证券之星 · 06-23
6月23日舒泰神涨11.22%，景顺长城医疗健康混合A基金重仓该股
舒泰神：2026年7月8日召开2026年第一次临时股东会
证券日报 · 06-22
舒泰神：2026年7月8日召开2026年第一次临时股东会
舒泰神（300204）披露药品生产许可证变更公告，6月16日股价下跌0.87%
证券之星 · 06-16
舒泰神（300204）披露药品生产许可证变更公告，6月16日股价下跌0.87%
6月11日舒泰神跌6.81%，景顺长城医疗健康混合A基金重仓该股
证券之星 · 06-11
6月11日舒泰神跌6.81%，景顺长城医疗健康混合A基金重仓该股
舒泰神：子公司博佳凝获得药品注册证书
证券之星 · 06-10
舒泰神：子公司博佳凝获得药品注册证书
舒泰神最新公告：子公司药品博佳凝获国家药监局注册证书
证券之星 · 06-09
舒泰神最新公告：子公司药品博佳凝获国家药监局注册证书
6月8日舒泰神跌5.04%，景顺长城医疗健康混合A基金重仓该股
证券之星 · 06-08
6月8日舒泰神跌5.04%，景顺长城医疗健康混合A基金重仓该股
5月29日舒泰神涨9.28%，景顺长城医疗健康混合A基金重仓该股
证券之星 · 05-29
5月29日舒泰神涨9.28%，景顺长城医疗健康混合A基金重仓该股
舒泰神（300204）发布2025年年度股东会决议公告，5月20日股价下跌0.34%
证券之星 · 05-20
舒泰神（300204）发布2025年年度股东会决议公告，5月20日股价下跌0.34%
舒泰神最新公告：向特定对象发行股票获证监会同意注册批复
证券之星 · 05-18
舒泰神最新公告：向特定对象发行股票获证监会同意注册批复
舒泰神（300204）披露召开2025年年度股东会提示性公告，5月14日股价下跌1.88%
证券之星 · 05-14
舒泰神（300204）披露召开2025年年度股东会提示性公告，5月14日股价下跌1.88%
舒泰神：聘任李世诚先生担任公司副总经理
证券之星 · 05-08
舒泰神：聘任李世诚先生担任公司副总经理
每周股票复盘：舒泰神（300204）2025年亏损收窄但2026Q1净利下滑261%
证券之星 · 05-03
每周股票复盘：舒泰神（300204）2025年亏损收窄但2026Q1净利下滑261%
舒泰神：继续推进注射用STSP-0601附条件批准上市工作
证券之星 · 04-30
舒泰神：继续推进注射用STSP-0601附条件批准上市工作
舒泰神（300204）2026年一季报简析：净利润同比下降261.1%
中金财经 · 04-29
舒泰神（300204）2026年一季报简析：净利润同比下降261.1%
加载更多
公司概况
公司名称：
舒泰神(北京)生物制药股份有限公司
所属行业：
医药制造业
上市日期：
2011-04-15
主营业务：
舒泰神(北京)生物制药股份有限公司的主营业务是生物药物的研发、生产和营销。公司的主要产品是苏肽生、舒泰清。公司是国家级高新技术企业。
发行价格：
52.50
{"stockData":{"symbol":"300204","market":"SZ","secType":"STK","nameCN":"舒泰神","latestPrice":24.21,"timestamp":1783666995000,"preClose":23.18,"halted":0,"volume":53563173,"delay":0,"changeRate":0.0444,"floatShares":454000000,"shares":478000000,"eps":-0.1756,"marketStatus":"已收盘","change":1.03,"latestTime":"07-10 15:00:00","open":22.78,"high":25.12,"low":22.38,"amount":1287000000,"amplitude":0.1182,"askPrice":24.22,"askSize":41,"bidPrice":24.21,"bidSize":102,"shortable":0,"etf":0,"ttmEps":-0.1756,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1783906200000},"marketStatusCode":5,"adr":0,"adjPreClose":23.18,"symbolType":"stock","openAndCloseTimeList":[[1783647000000,1783654200000],[1783659600000,1783666800000]],"highLimit":25.5,"lowLimit":20.86,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":477772555,"isCdr":false,"pbRate":13.68,"roa":"--","roe":"--","epsLYR":-0.16,"committee":0.842378,"marketValue":11567000000,"turnoverRate":0.1181,"status":0,"floatMarketCap":10983000000},"requestUrl":"/m/hq/s/300204","defaultTab":"news","newsList":[{"id":"2649499109","title":"舒泰神（300204）披露药品生产许可证变更公告，7月8日股价下跌3.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2649499109","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649499109?lang=zh_cn&edition=full","pubTime":"2026-07-08 22:14","pubTimestamp":1783520061,"startTime":"0","endTime":"0","summary":"截至2026年7月8日收盘，舒泰神报收于23.75元，较前一交易日下跌3.06%，最新总市值为113.47亿元。该股当日开盘24.06元，最高25.8元，最低23.66元，成交额达11.04亿元，换手率为9.87%。舒泰神（北京）生物制药股份有限公司近日取得北京市药品监督管理局换发的《药品生产许可证》，同意公司位于北京经济技术开发区经海二路36号的生产地址及生产范围通过GMP符合性检查，具体包括治疗用生物制品及委托生产品种注射用波米泰酶α。本次变更对公司业绩无重大影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070800042627.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300204","BK0028","BK0046","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649640947","title":"舒泰神（300204）披露召开2026年第一次临时股东会提示性公告，7月6日股价上涨4.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2649640947","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649640947?lang=zh_cn&edition=full","pubTime":"2026-07-06 17:31","pubTimestamp":1783330310,"startTime":"0","endTime":"0","summary":"截至2026年7月6日收盘，舒泰神报收于25.35元，较前一交易日上涨4.93%，最新总市值为121.12亿元。该股当日开盘23.35元，最高27.79元，最低23.11元，成交额达18.1亿元，换手率为15.62%。近日，舒泰神（北京）生物制药股份有限公司发布《关于召开2026年第一次临时股东会的提示性公告》。公告显示，公司将于2026年07月08日召开2026年第一次临时股东会，会议采取现场表决与网络投票相结合的方式。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070600024320.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300204","BK0046","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648516670","title":"7月1日舒泰神涨5.80%，景顺长城医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2648516670","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648516670?lang=zh_cn&edition=full","pubTime":"2026-07-01 16:51","pubTimestamp":1782895882,"startTime":"0","endTime":"0","summary":"证券之星消息，7月1日舒泰神涨5.80%，收盘报25.16元，换手率15.74%，成交量71.4万手，成交额17.55亿元。重仓舒泰神的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共4家，其中持有数量最多的公募基金为景顺长城基金的景顺长城医疗健康混合A。景顺长城医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100031670.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0028","300204","BK0239","159760"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646589983","title":"6月26日舒泰神跌7.62%，景顺长城医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2646589983","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646589983?lang=zh_cn&edition=full","pubTime":"2026-06-26 16:55","pubTimestamp":1782464159,"startTime":"0","endTime":"0","summary":"证券之星消息，6月26日舒泰神跌7.62%，收盘报19.4元，换手率5.98%，成交量27.14万手，成交额5.44亿元。重仓舒泰神的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共4家，其中持有数量最多的公募基金为景顺长城基金的景顺长城医疗健康混合A。景顺长城医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600030732.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","159760","BK0028","300204"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645895403","title":"6月24日舒泰神跌6.19%，景顺长城医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2645895403","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645895403?lang=zh_cn&edition=full","pubTime":"2026-06-24 16:46","pubTimestamp":1782290787,"startTime":"0","endTime":"0","summary":"证券之星消息，6月24日舒泰神跌6.19%，收盘报21.2元，换手率9.09%，成交量41.25万手，成交额8.92亿元。重仓舒泰神的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共4家，其中持有数量最多的公募基金为景顺长城基金的景顺长城医疗健康混合A。景顺长城医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062400030268.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","159760","300204","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645816048","title":"6月23日舒泰神涨11.22%，景顺长城医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2645816048","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645816048?lang=zh_cn&edition=full","pubTime":"2026-06-23 16:38","pubTimestamp":1782203897,"startTime":"0","endTime":"0","summary":"证券之星消息，6月23日舒泰神涨11.22%，收盘报22.6元，换手率12.56%，成交量56.99万手，成交额12.79亿元。重仓舒泰神的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共4家，其中持有数量最多的公募基金为景顺长城基金的景顺长城医疗健康混合A。景顺长城医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300028103.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","159760","BK0239","300204","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645078321","title":"舒泰神：2026年7月8日召开2026年第一次临时股东会","url":"https://stock-news.laohu8.com/highlight/detail?id=2645078321","media":"证券日报 ","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645078321?lang=zh_cn&edition=full","pubTime":"2026-06-22 21:12","pubTimestamp":1782133920,"startTime":"0","endTime":"0","summary":"证券日报网讯 6月22日，舒泰神发布公告称，公司将于2026年7月8日召开2026年第一次临时股东会。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-06-22/doc-iniehwmq2478373.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-06-22/doc-iniehwmq2478373.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0046","BK0239","300204","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643758065","title":"舒泰神（300204）披露药品生产许可证变更公告，6月16日股价下跌0.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2643758065","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643758065?lang=zh_cn&edition=full","pubTime":"2026-06-16 17:40","pubTimestamp":1781602827,"startTime":"0","endTime":"0","summary":"截至2026年6月16日收盘，舒泰神报收于20.56元，较前一交易日下跌0.87%，最新总市值为98.23亿元。该股当日开盘20.78元，最高21.18元，最低20.42元，成交额达3.28亿元，换手率为3.49%。近日，舒泰神（北京）生物制药股份有限公司发布公告称，公司近期取得北京市药品监督管理局换发的《药品生产许可证》，同意将药品名称由“注射用 STSP-0601”变更为“注射用波米泰酶α”，并在该药品后标注药品批准文号国药准字S20260040。本次变更对公司业绩无重大影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600031790.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","300204","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642407219","title":"6月11日舒泰神跌6.81%，景顺长城医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2642407219","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642407219?lang=zh_cn&edition=full","pubTime":"2026-06-11 16:32","pubTimestamp":1781166759,"startTime":"0","endTime":"0","summary":"证券之星消息，6月11日舒泰神跌6.81%创60日新低，收盘报20.38元，换手率6.08%，成交量27.59万手，成交额5.71亿元。重仓舒泰神的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共4家，其中持有数量最多的公募基金为景顺长城基金的景顺长城医疗健康混合A。景顺长城医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061100025674.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","159760","BK0046","300204","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642426109","title":"舒泰神：子公司博佳凝获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2642426109","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642426109?lang=zh_cn&edition=full","pubTime":"2026-06-10 20:48","pubTimestamp":1781095697,"startTime":"0","endTime":"0","summary":"证券之星消息，舒泰神06月09日在投资者关系平台上答复投资者关心的问题。舒泰神（北京）生物制药股份有限公司子公司江苏贝捷泰生物科技有限公司于2026年06月09日收到了国家药品监督管理局核准签发的注射用STSP-0601《药品注册证书》，取得了该药品生产的注册批件。相关事项您可查阅公司于2026年06月09日在巨潮资讯网披露的《关于子公司药品博佳凝获得药品注册证书的公告》。感谢您对公司的关注，谢谢！","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061000039789.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300204","BK0239","BK0028","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642173465","title":"舒泰神最新公告：子公司药品博佳凝获国家药监局注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2642173465","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642173465?lang=zh_cn&edition=full","pubTime":"2026-06-09 17:13","pubTimestamp":1780996428,"startTime":"0","endTime":"0","summary":"舒泰神(300204.SZ)公告称，公司子公司江苏贝捷泰生物科技有限公司收到国家药监局核准签发的注射用波米泰酶α(商品名：博佳凝)《药品注册证书》，该药品为治疗用生物制品1类，适用于凝血因子VIII或IX的抑制物＞5个Bethesda单位的先天性血友病A或B成人患者的出血治疗。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060900027940.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300204","BK0028","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641100838","title":"6月8日舒泰神跌5.04%，景顺长城医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2641100838","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641100838?lang=zh_cn&edition=full","pubTime":"2026-06-08 16:57","pubTimestamp":1780909074,"startTime":"0","endTime":"0","summary":"证券之星消息，6月8日舒泰神跌5.04%，收盘报23.57元，换手率5.18%，成交量23.5万手，成交额5.68亿元。重仓舒泰神的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共4家，其中持有数量最多的公募基金为景顺长城基金的景顺长城医疗健康混合A。景顺长城医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060800022551.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159760","BK0028","300204","BK0239","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639233936","title":"5月29日舒泰神涨9.28%，景顺长城医疗健康混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2639233936","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639233936?lang=zh_cn&edition=full","pubTime":"2026-05-29 16:54","pubTimestamp":1780044866,"startTime":"0","endTime":"0","summary":"证券之星消息，5月29日舒泰神涨9.28%，收盘报25.78元，换手率13.28%，成交量60.23万手，成交额15.63亿元。重仓舒泰神的公募基金请见下表：根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共4家，其中持有数量最多的公募基金为景顺长城基金的景顺长城医疗健康混合A。景顺长城医疗健康混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052900030637.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300204","159760","BK0028","BK0046","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636848859","title":"舒泰神（300204）发布2025年年度股东会决议公告，5月20日股价下跌0.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636848859","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636848859?lang=zh_cn&edition=full","pubTime":"2026-05-20 17:35","pubTimestamp":1779269732,"startTime":"0","endTime":"0","summary":"截至2026年5月20日收盘，舒泰神报收于26.58元，较前一交易日下跌0.34%，最新总市值为126.99亿元。该股当日开盘26.55元，最高27.0元，最低26.23元，成交额达3.34亿元，换手率为2.77%。近日，舒泰神（北京）生物制药股份有限公司发布《2025年年度股东会决议公告》。会议表决结果均获高比例同意，中小投资者参与表决并单独计票。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052000033813.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300204","BK0028","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636267990","title":"舒泰神最新公告：向特定对象发行股票获证监会同意注册批复","url":"https://stock-news.laohu8.com/highlight/detail?id=2636267990","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636267990?lang=zh_cn&edition=full","pubTime":"2026-05-18 17:19","pubTimestamp":1779095970,"startTime":"0","endTime":"0","summary":"舒泰神(300204.SZ)公告称，公司收到证监会出具的批复，同意公司向特定对象发行股票的注册申请。本次发行应严格按照报送深交所的申报文件和发行方案实施，批复自同意注册之日起12个月内有效。公司董事会将按规定办理相关事宜并及时履行信息披露义务。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800024776.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300204","BK0239","BK0046","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635745250","title":"舒泰神（300204）披露召开2025年年度股东会提示性公告，5月14日股价下跌1.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635745250","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635745250?lang=zh_cn&edition=full","pubTime":"2026-05-14 22:24","pubTimestamp":1778768656,"startTime":"0","endTime":"0","summary":"截至2026年5月14日收盘，舒泰神报收于27.65元，较前一交易日下跌1.88%，最新总市值为132.1亿元。该股当日开盘28.18元，最高28.9元，最低27.6元，成交额达5.94亿元，换手率为4.67%。舒泰神（北京）生物制药股份有限公司于2026年5月14日发布《关于召开2025年年度股东会的提示性公告》。公告显示，公司定于2026年5月19日召开2025年年度股东会，会议采取现场表决与网络投票相结合的方式。股权登记日为2026年5月11日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051400043008.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0239","BK0028","300204"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633019591","title":"舒泰神：聘任李世诚先生担任公司副总经理","url":"https://stock-news.laohu8.com/highlight/detail?id=2633019591","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633019591?lang=zh_cn&edition=full","pubTime":"2026-05-08 08:42","pubTimestamp":1778200933,"startTime":"0","endTime":"0","summary":"证券之星消息，舒泰神05月07日在投资者关系平台上答复投资者关心的问题。公司于2025年03月23日召开第六届董事会第六次会议，审议通过了《关于公司聘任高级管理人员的议案》，聘任李世诚先生担任公司副总经理、白雪莲女士担任公司临床研究中心总经理、王静峰先生担任公司营销自营事业部总经理、张蕾女士担任公司人力资源总监、田磊先生担任公司生产中心总监。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800007594.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0046","300204","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632467425","title":"每周股票复盘：舒泰神（300204）2025年亏损收窄但2026Q1净利下滑261%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632467425","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632467425?lang=zh_cn&edition=full","pubTime":"2026-05-03 03:19","pubTimestamp":1777749550,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，舒泰神报收于27.63元，较上周的28.07元下跌1.57%。本周，舒泰神4月28日盘中最高价报29.17元。本周关注点来自业绩披露要点：舒泰神2025年归母净利润-7776.33万元，同比上升46.31%。股本股东变化截至2026年3月31日，公司股东户数为8.27万户，较2025年12月31日增加1.9万户，增幅29.94%。2025年研发投入占营收比例达70.81%。预计2026年度与关联方发生日常关联交易总额不超过12,682.22万元。公司将于2026年5月20日举行2025年度业绩网上说明会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050300000644.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0046","300204"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631637027","title":"舒泰神：继续推进注射用STSP-0601附条件批准上市工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2631637027","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631637027?lang=zh_cn&edition=full","pubTime":"2026-04-30 20:48","pubTimestamp":1777553294,"startTime":"0","endTime":"0","summary":"证券之星消息，舒泰神(300204)04月29日在投资者关系平台上答复投资者关心的问题。投资者提问：公司的0601迟迟没批复，是否存在被否的可能性？如果被否，公司怎么维持日常现金流？舒泰神回复：您好！公司前期已按照发补通知要求组织相关部门落实并补充提交了相关材料，继续推进注射用STSP-0601附条件批准上市工作。有关研发项目进展，敬请关注CDE平台公示、后续定期报告及项目进展公告。如您希望对公司进行更多了解，欢迎您致电公司投资者热线（010-67875255），谢谢！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000065831.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0239","300204","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631555280","title":"舒泰神（300204）2026年一季报简析：净利润同比下降261.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631555280","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631555280?lang=zh_cn&edition=full","pubTime":"2026-04-29 09:07","pubTimestamp":1777424869,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期舒泰神发布2026年一季报。根据财报显示，舒泰神净利润同比下降261.1%。截至本报告期末，公司营业总收入4689.77万元，同比下降25.81%，归母净利润-843.18万元，同比下降261.1%。本次财报公布的各项数据指标表现不尽如人意。生意拆解：公司过去三年净经营资产收益率分别为--/--/--，净经营利润分别为-3.99亿/-1.48亿/-8810.52万元，净经营资产分别为3.71亿/3.28亿/3.31亿元。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202604/29/20260429852813.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202604/29/20260429852813.png"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260429/32187662.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["300204"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1783689615622,"stockEarnings":[{"period":"1week","weight":-0.0338},{"period":"1month","weight":0.0432},{"period":"3month","weight":-0.1985},{"period":"6month","weight":-0.2474},{"period":"1year","weight":-0.4277},{"period":"ytd","weight":-0.1515}],"compareEarnings":[{"period":"1week","weight":0.0019},{"period":"1month","weight":0.0066},{"period":"3month","weight":0.0126},{"period":"6month","weight":-0.0203},{"period":"1year","weight":0.1556},{"period":"ytd","weight":0.0171}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"舒泰神(北京)生物制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"82652人(较上一季度增加29.94%)","perCapita":"5488股","listingDate":"2011-04-15","address":"北京市大兴区北京经济技术开发区经海二路36号","registeredCapital":"47777万元","survey":" 舒泰神(北京)生物制药股份有限公司的主营业务是生物药物的研发、生产和营销。公司的主要产品是苏肽生、舒泰清。公司是国家级高新技术企业。","listedPrice":52.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"舒泰神(300204)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供舒泰神(300204)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"舒泰神,300204,舒泰神股票,舒泰神股票老虎,舒泰神股票老虎国际,舒泰神行情,舒泰神股票行情,舒泰神股价,舒泰神股市,舒泰神股票价格,舒泰神股票交易,舒泰神股票购买,舒泰神股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"舒泰神(300204)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供舒泰神(300204)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}